U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07221344) titled 'Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease' on Oct. 23.
Brief Summary: Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of ARO-MAPT-SC compared to placebo in adult healthy volunteers and in participants with early Alzheimer's disease (AD), defined as mild cognitive impairment due to AD and mild AD dementia.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Alzheimer Disease, Early Onset
Intervention:
DRUG: ARO-MAPT-SC
* single or multiple doses of ARO-MAPT-SC by subcutaneous (SC) injection
DRUG: Placebo
* calc...